Laura Deming
InvestorFounderPartner at age1 · Founder at Longevity Fund
Palo Alto, California
Writes $100K – $1M checks · typically $500K
FoundedLongevity Fund
Find your path to Laura
163 people in our graph share verified history with Laura — schools, employers, funds. One of them is your warm intro.
Mira ChaurushiyaunlockedLaura: together at Genentech (2011)
×8Laura: together at Genentech
×3Laura: together at The Thiel Foundation
About
Laura Deming is CEO and co-founder of Until, a company focused on aging and age-related disease. She began working in biogerontology at age 12 and attended MIT starting at age 14. Deming was a Thiel Fellow at 17 and has worked as a venture capital partner at The Longevity Fund, investing in gene editing, small molecule therapeutics, and disease treatment approaches.
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtech
Founder at Longevity Fund
Intro paths
→
In turn, Laura can intro founders to Longevity Fund's investors below.
Longevity Fund's investors · 2
Experience
- UntilCEO, co-foundercurrent2024 — presentSouth San Francisco, California, United States
- age1Partnercurrent2023 — presentSan Francisco Bay Area
- The Longevity FundPartnercurrent2011 — presentSan Francisco
- Alexo Therapeutics.2015 — 2016
- The Thiel FoundationThiel Fellow2011 — 2013San Francisco
- GenentechResearcher - Firestein Lab2011South San Francisco
- Weiss Lab, MITResearcher2010 — 2011
- iGEM (International Genetically Engineered Machine Competition), MITResearcher2010
- Guarente Laboratory (MIT)Researcher2009 — 2010
- Kenyon Laboratory (UCSF)Researcher2006 — 2009
Skills & more
Biochemistry41Genetics27Regenerative Medicine8Cell Based Assays3Protein Chemistry14DNA14Cancer15Cell17Lifesciences28
From Laura's professional profile.
Colleagues at age1
Alex Colville
Co-Founder, General Partner at age1
Carol Magalhaes
NewCo Chief of Staff at age1
Carolin Althoff
General Partner - Investor & Head of ESG at Cusp Capital
Doug Henze
Venture Fellow at age1
Dr. Carolin Althoff
General Partner - Investor & Head of ESG at Cusp Capital
Lauren Naworski
Venture Fellow at age1
Lily Clayton
Head of Operations at age1
Maggie Li
Special Projects Lead at age1
Frequently asked questions
- Who is Laura Deming?
- Laura Deming is CEO and co-founder of Until, a company focused on aging and age-related disease. She began working in biogerontology at age 12 and attended MIT starting at age 14. Deming was a Thiel Fellow at 17 and has worked as a venture capital partner at The Longevity Fund, investing in gene editing, small molecule therapeutics, and disease treatment approaches.
- Where does Laura Deming work?
- Laura Deming is Founder of Longevity Fund and Partner at age1.
- What does Laura Deming invest in?
- Laura Deming invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech.
- What check size does Laura Deming write?
- Laura Deming typically writes checks of $100K – $1M.
- What companies did Laura Deming found?
- Laura Deming founded Longevity Fund.
- Where did Laura Deming go to school?
- Laura Deming studied at Massachussetts Institute of Technology (MIT) (On Leave from a Bachelor of Science, Physics and Biology); University of California, San Francisco.
Same school
Also attended University of California, San Francisco170
Douglas CrawfordManaging General Partner at Mission BiocapitalLuke EvninAdvisor at MPM BioImpactCharles White, Ph.D.Principal at Illumina VenturesMatt MaurerInvestor at WVV CapitalAlec NielsenFounder & CEO, Asimov & Venture Partner at Pillar VCStephan ChristgauFounding Partner at EIR Ventures
+ 164 more
Shared employers
Also worked at Until1
Also worked at The Longevity Fund3
Also worked at The Thiel Foundation52
Ritesh AgarwalFounder & CEO of OYOSebastian CaliriInvestment Team at 8VCKevin WangCEO, FOSSA Inc. at OSS CapitalAndrew BrackinPartner at Gradient investing across vertical AI, healthcare, and the application layerIan LeePrincipal at Signum CapitalDanielle StrachmanInvestor at NZVC
+ 46 more
Also worked at Genentech246
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 240 more